Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Immunomedics, Inc.
ClinicalTrials.gov Identifier:
NCT00547066
First received: October 17, 2007
Last updated: May 23, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
No publications provided by Immunomedics, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):